DAPI-inducible common fragile sites
- 1 January 1986
- journal article
- research article
- Published by S. Karger AG in Cytogenetic and Genome Research
- Vol. 42 (3) , 174-176
- https://doi.org/10.1159/000132272
Abstract
DAPI, a compound specific for the AT bases of DNA, causes gaps and breaks in three human chromosome sites, at the 1q41 1q42 interface, 2q31, and 7p22. It also induces undercondensation of a chromosome site at the 13q21–13q22 interface. The first three sites have the characteristics of “common fragile sites” and are present as gaps and breaks on the chromosomes of seven individuals.This publication has 8 references indexed in Scilit:
- New classes of common fragile sites induced by 5-azacytidine and bromodeoxyuridineHuman Genetics, 1985
- Constitutive Fragile Sites and CancerScience, 1984
- Nonrandom distribution of methotrexate-induced aberrations on human chromosomes. Detection of further folic acid sensitive fragile sitesHuman Genetics, 1984
- DNA polymerase ? inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomesHuman Genetics, 1984
- Inhibition of human chromosome condensation induced by DAPI as related to cell cycleExperimental Cell Research, 1981
- Demonstration of a heritable fragile site in human chromosome 16 with distamycin ACytogenetic and Genome Research, 1980
- Optical studies of the interaction of 4?-6-diamidino-2-phenylindole with DNA and metaphase chromosomesChromosoma, 1977
- Adenovirus 12 uncoiler regions of human chromosome 1 in relation to the 5S rRNA genesExperimental Cell Research, 1976